Novogen's NV-128, a Novel mTOR Inhibitor, Shows Potential Activity Against Cancer Stem Cells
01 déc. 2008 08h10 HE
|
NOVOGEN LIMITED
SYDNEY, AUSTRALIA and NEW CANAAN, CT--(Marketwire - December 1, 2008) - Pharmaceutical company
Novogen Limited (NASDAQ: NVGN) (ASX: NRT) today announced that work
performed in collaboration with a...